SGLT2 Inhibitors Not Recommended for ADPKD Patients by KDIGO
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, widely used to treat chronic kidney disease and heart failure, are currently not recommended for patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Clinical Care … Read More